P2Y Receptor
All Product Categories
-
P2Y Receptor Inhibitors
(42)
View all products
-
P2Y Receptor Agonists
(22)
View all products
-
P2Y Receptor Antagonists
(35)
View all products
-
P2Y Receptor Activators
(4)
View all products
-
P2Y Receptor Modulators
(2)
View all products
-
P2Y Receptor Controls
(3)
View all products
-
P2Y Receptor Ligands
(2)
View all products
-
P2Y Receptor Related Products (122)
Related Products (122)
-
MRS2690 disodium
0 ImagesCat. No.: HY-116295AMRS2690 disodium is a selective P2Y14 receptor agonist. MRS2690 disodium inhibits adenylyl cyclase activity, thereby reducing intracellular cAMP levels and mediating concentration-dependent vasoconstriction of porcine coronary arteries. MRS2690 disodium induces intracellular calcium mobilization, activates P38 and stimulates [35S]GTPγS binding to RBL-2H3 cell membranes. MRS2690 enhances antigen (NP-BSA)-, C3a-induced β-hexosaminidase (β-Hex) release. MRS2690 disodium can be used for ischemic heart disease.
-
P2ry13 Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09923P2ry13 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2ry13 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2ry12 Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09920P2ry12 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2ry12 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2RY1 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09914P2RY1 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RY1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2ry14 Rat Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09927P2ry14 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2ry14 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2ry12 Rat Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09921P2ry12 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2ry12 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2Y14 antagonist 1
0 ImagesCat. No.: HY-170950P2Y14 antagonist 1 (compound 45) is a high selective and orally active P2Y14R antagonist with an IC50 of 0.70 nM. P2Y14R antagonist 1 demonstrates significant anti-inflammatory efficacy, effectively mitigating the pulmonary infiltration of immune cells and inflammatory response through suppressing the NLRP3 signaling pathway. P2Y14R antagonist 1 has the potential for the research of acute lung injury.
-
P2ry14 Mouse Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09926P2ry14 Mouse Pre-designed siRNA Set A contains three designed siRNAs for P2ry14 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
SAR216471
0 ImagesCat. No.: HY-12435CAS No.: 1279867-21-8SAR216471 is a P2Y12 receptor antagonist. SAR216471 reversibly blocks the binding of 2MeSADP to P2Y12 receptors in vitro with an IC50 of 17 nM. SAR216471 can result in the inhibition of platelet aggregation. SAR216471 exhibits anti-thrombotic activity in rat model. SAR216471 can be studied in research on thrombosis.
-
Rp-UTP-α-S tetrasodium
0 ImagesCat. No.: HY-137612CSynonyms: Rp-Uridine 5'-O-1-thiotriphosphate tetrasodiumRp-UTP-α-S (Rp-Uridine 5'-O-(1-thiotriphosphate)) tetrasodium is a nucleotide agonist of purinergic P2Y2 and P2Y4 receptors. Rp-UTP-α-S (tetrasodium) can induce inositol phosphate accumulation in P2Y2 or P2Y4 expressing 1321N1 cells with EC50 values of 5.4 and 27 μM.
-
ADP-β-S trisodium
0 ImagesCat. No.: HY-134353ASynonyms: Adenosine 5'-(β-thiodiphosphate) trisodiumADP-β-S (Adenosine 5'-(β-thiodiphosphate)) trilithium is a non-hydrolyzable ADP analog and a P2Y12 receptor agonist. ADP-β-S trilithium activates the P2Y12 receptor in microglia, thereby triggering downstream inflammatory signaling pathways. ADP-β-S trilithium activates P2Y purinergic receptors in rat pancreatic β cells and enhances glucose-induced insulin secretion. ADP-β-S trilithium can be used in the research of diseases such as inflammation and diabetes.
-
Prasugrel-d4
0 ImagesCat. No.: HY-15284S2CAS No.: 1189919-49-0Synonyms: PCR 4099-d4Prasugrel-d4 is the deuterium labeled Prasugrel. Prasugrel (PCR 4099), a thienopyridine and proagent, inhibits platelet function. Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits ADP-induced platelet aggregation.
-
P2ry1 Rat Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09916P2ry1 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2ry1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2RY14 Human Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09925P2RY14 Human Pre-designed siRNA Set A contains three designed siRNAs for P2RY14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
P2ry4 Rat Pre-designed siRNA Set A
0 ImagesCat. No.: HY-RS09933P2ry4 Rat Pre-designed siRNA Set A contains three designed siRNAs for P2ry4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
-
MRS4865
0 ImagesCat. No.: HY-168139CAS No.: 2801624-14-4MRS4865 (compund 7a) is a chimera of a P2Y14 receptor antagonist and a UDP-glucose agonist that protects against neuropathic pain.
-
PPTN mesylate
0 ImagesCat. No.: HY-103055CAS No.: 1160271-31-7PPTN mesylate is a potent, high-affinity, competitive and highly selective P2Y14 receptor antagonist with a KB value of 434 pM. PPTN mesylate exhibits no agonist or antagonist effect at the P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, or P2Y13 receptors. Anti-inflammatory and immune activity.
-
(Rac)-Clopidogrel hydrogen-d9 sulfate
0 ImagesCat. No.: HY-107867S1(Rac)-Clopidogrel hydrogen-d9 sulfate is the deuterium labeled (±)-Clopidogrel (bisulfate) (HY-107867). (±)-Clopidogrel bisulfate is a platelet P2Y12 receptor inhibitor and an adenosine diphosphate (ADP) receptor antagonist. (±)-Clopidogrel bisulfate inhibits the binding of ADP to its receptors on the membranes of platelet cells, and blocks ADP-mediated activation of the glycoprotein GPIIb/IIIa complex. (±)-Clopidogrel bisulfate reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. (±)-Clopidogrel bisulfate has anti-inflammatory effects.
-
Clopidogrel thiolactone (Standard)
0 ImagesCat. No.: HY-15876RCAS No.: 1147350-75-1Cyhalofop (Standard) is the analytical standard of Cyhalofop. This product is intended for research and analytical applications. Cyhalofop (Cyhalofop acid), the primary metabolite of Cyhalofop-butyl (HY-B0861) in susceptible grasses, is the herbicidally active metabolite. Cyhalofop-butyl is an aryloxyphenoxypropionate post-emergence herbicide widely used around the world in agriculture.
